title: Growth after intestinal transplant in children.
abstract: Intestinal transplantation has been more frequent in children with intestinal failure. However, the growth after intestinal transplantation has not been well documented. The demographics, transplant information, postoperative complications, heights, and weights were obtained retrospectively from medical records on 23 children who underwent intestinal transplantation. Z-scores were calculated from the STAT Growth-BP, based on Centers for Disease Control and Prevention growth chart (2000). Transplantations were performed between 1999 and 2004. Patient median age was 1.1 years (range 0.5 to 6.9 years). Twelve were boys and 11 girls. Seventeen children received multivisceral transplantations, one modified multivisceral transplantation, and five isolated intestinal transplantations. Baseline immunosuppression consisted of tacrolimus and corticosteroids. Daclizumab was used as induction agent in 18 patients; alemtuzumab, in five patients. Median pretransplant Z-scores were median -1.67 (n = 23) in weight, and median -3.36 (n = 21) in height. Pretransplant growth was significantly retarded. We analyzed significantly retarded patients with Z-score <-2.0. The change of weight Z-score from pretransplant was: 1.25 at 6 months (n = 11), 1.46 at 12 months (n = 10), and 2.21 at 24 months (n = 7). The change of height Z-score: 1.9 at 6 months (n = 16), 1.42 at 12 months (n = 13), and 1.51 at 24 months (n = 10). Z-score significantly improved (P < .002, ANOVA). Among the analyzed factors sex, age at transplant, length of stay, and rejection within 6 months, were not associated with catch-up growth. Children with retarded growth showed significant catch-up after successful intestinal transplantation.
authors.affiliation: Department of Surgery, University of Miami, Miami, Florida, USA.
authors.forename: T
authors.initials: T
authors.lastname: Ueno
authors.forename: T
authors.initials: T
authors.lastname: Kato
authors.forename: K
authors.initials: K
authors.lastname: Revas
authors.forename: J
authors.initials: J
authors.lastname: Gaynor
authors.forename: M
authors.initials: M
authors.lastname: Velasco
authors.forename: G
authors.initials: G
authors.lastname: Selvaggi
authors.forename: G
authors.initials: G
authors.lastname: McLaughlin
authors.forename: E
authors.initials: E
authors.lastname: Hernandez
authors.forename: R E
authors.initials: RE
authors.lastname: Kramer
authors.forename: R
authors.initials: R
authors.lastname: Krame
authors.forename: J
authors.initials: J
authors.lastname: Thompson
authors.forename: A
authors.initials: A
authors.lastname: Tzakis
mesh_terms: D001827:Body Height; D001835:Body Weight; D002648:Child; D002675:Child, Preschool; D005260:Female; D006128:Growth / Q000502:physiology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007223:Infant; D007422:Intestines / Q000637:transplantation*; D008297:Male; D011446:Prospective Studies; D012778:Short Bowel Syndrome / Q000601:surgery*; D014184:Transplantation, Homologous / Q000276:immunology / Q000502:physiology